Come up with a name for your new list and we'll add to it:
BioVidria raised a round of funding on July 09, 2009. Investors include
Qualifying Therapeutic Discovery Project.
BioVidria is commercializing high-sensitivity slides for DNA and protein microarrays. The technology utilizes a patented process to provide high surface area and optical transparency. This aims to off…